Apricus Biosciences Further Expands Existing Vitaros Partnership with ...
Apricus Biosciences, Inc. , a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has further expanded its exclusive distribution agreement with Ferring Pharmaceuticals , for the commercialization of VitarosA , Apricus' novel topical on-demand treatment for erectile dysfunction . This amendment is in addition to the in-place collaboration established with Ferring in Latin America in 2015, and the recently announced expansion for the United Kingdom.
from Biotech News
0 Comments